Treatment of Abdominal Abscesses With or Without Fibrinolysis
1 other identifier
interventional
92
1 country
1
Brief Summary
The objective of this study is to evaluate the utility of fibrinolysis when draining an abdominal abscess as defined by length of stay after drainage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
May 10, 2012
CompletedFirst Posted
Study publicly available on registry
May 14, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedFebruary 4, 2015
February 1, 2015
4.6 years
May 10, 2012
February 3, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Length of hospital stay
Length of time required for meeting discharge criteria
1-2 weeks
Study Arms (2)
Saline only flush of abscess
ACTIVE COMPARATORSaline alone used to flush abscess
Saline plus tPA flush of abscess
EXPERIMENTALSaline plus tPA used for abscess flush
Interventions
Thirteen ml of 10% tPA in saline at time of drain and twice daily thereafter.
Thirteen ml of saline is used to flush abscess at time of drain placement and twice daily thereafter.
Eligibility Criteria
You may qualify if:
- Patients under age 18 found to have an abscess in their abdomen related to perforated appendicitis that requires a drain either prior to or after appendectomy.
You may not qualify if:
- Patients with known immune deficiency per medical record review
- Patients with another condition affecting surgical decision making or recovery
- Patients with drain unable to be placed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shawn D St. Peter, MD
Children's Mercy Hospital and Clinics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 10, 2012
First Posted
May 14, 2012
Study Start
June 1, 2009
Primary Completion
January 1, 2014
Study Completion
May 1, 2014
Last Updated
February 4, 2015
Record last verified: 2015-02